"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","centre:ch1","disease state:ch1","sample type:ch1"
"GSM3151643","control [Beaumont]","GSM3151643","Public on Jan 02 2019","May 23 2018","Jan 02 2019","SRA","1","plasma","Homo sapiens","sample type: 16 pooled samples","disease state: Control","centre: Beaumont","total RNA","Total RNA was extracted from 200 μl of plasma using the miRCURY RNA isolation kit-biofluid (Exiqon) according to the manufacturer’s protocol","Next Generation Sequencing process for biofluids microRNA and small RNA sequencing at Exiqon.","9606","Total RNA was extracted from 200 μl of plasma using the miRCURY RNA isolation kit for biofluids (Exiqon).","Purified RNA was eluted in 50 μl RNAase free water. Total RNA was extracted using miRCURY RNA isolation kit and small RNA libraries were generated using NEBNEXT library generation kit (New England Biolabs Inc.).","Samples were sequenced on the Illumina system by Exiqon Services, Denmark.","Intensity correction, base calling and assigning of Q-scores were then performed as part of measures to assess the quality of the data obtained.","Differential expression analysis was performed using the EdgeR statistical software package.","GPL18573","Catherine,,Mooney","catherine.mooney@ucd.ie","School of Computer Science","University College Dublin","Belfield","Dublin","4","Ireland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09244464","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4118662","NONE","Beaumont","Control","16 pooled samples"
"GSM3151644","EBS [Beaumont]","GSM3151644","Public on Jan 02 2019","May 23 2018","Jan 02 2019","SRA","1","plasma","Homo sapiens","sample type: 16 pooled samples","disease state: Epilepsy, pre seizure","centre: Beaumont","total RNA","Total RNA was extracted from 200 μl of plasma using the miRCURY RNA isolation kit-biofluid (Exiqon) according to the manufacturer’s protocol","Next Generation Sequencing process for biofluids microRNA and small RNA sequencing at Exiqon.","9606","Total RNA was extracted from 200 μl of plasma using the miRCURY RNA isolation kit for biofluids (Exiqon).","Purified RNA was eluted in 50 μl RNAase free water. Total RNA was extracted using miRCURY RNA isolation kit and small RNA libraries were generated using NEBNEXT library generation kit (New England Biolabs Inc.).","Samples were sequenced on the Illumina system by Exiqon Services, Denmark.","Intensity correction, base calling and assigning of Q-scores were then performed as part of measures to assess the quality of the data obtained.","Differential expression analysis was performed using the EdgeR statistical software package.","GPL18573","Catherine,,Mooney","catherine.mooney@ucd.ie","School of Computer Science","University College Dublin","Belfield","Dublin","4","Ireland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09244463","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4118663","NONE","Beaumont","Epilepsy, pre seizure","16 pooled samples"
"GSM3151645","EAS [Beaumont]","GSM3151645","Public on Jan 02 2019","May 23 2018","Jan 02 2019","SRA","1","plasma","Homo sapiens","sample type: 16 pooled samples","disease state: Epilepsy, post seizure","centre: Beaumont","total RNA","Total RNA was extracted from 200 μl of plasma using the miRCURY RNA isolation kit-biofluid (Exiqon) according to the manufacturer’s protocol","Next Generation Sequencing process for biofluids microRNA and small RNA sequencing at Exiqon.","9606","Total RNA was extracted from 200 μl of plasma using the miRCURY RNA isolation kit for biofluids (Exiqon).","Purified RNA was eluted in 50 μl RNAase free water. Total RNA was extracted using miRCURY RNA isolation kit and small RNA libraries were generated using NEBNEXT library generation kit (New England Biolabs Inc.).","Samples were sequenced on the Illumina system by Exiqon Services, Denmark.","Intensity correction, base calling and assigning of Q-scores were then performed as part of measures to assess the quality of the data obtained.","Differential expression analysis was performed using the EdgeR statistical software package.","GPL18573","Catherine,,Mooney","catherine.mooney@ucd.ie","School of Computer Science","University College Dublin","Belfield","Dublin","4","Ireland","0","Illumina NextSeq 500","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN09244462","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX4118664","NONE","Beaumont","Epilepsy, post seizure","16 pooled samples"
